In fact, Hep3B spheroids treated with conditioned medium from THP-1 activated macrophages, incubated with sorafenib displayed reduced tumor growth, which was further reduced either by MCC950 addition or after administration in the conditioned medium of an IL-1 antagonist such as Anakinra (Supplemental Figure S4). This evidence concerns the gene IL1B and neoplasm.